Adherence to insulin treatment in insulin-naïve type 2 diabetic patients initiated on different insulin regimens
Open accessThe DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: We aimed to evaluate adherence to insulin treatment in terms of treatment persistence and daily adherence to insulin injections among insulin-naïve type 2 diabetic patients initiating insulin therapy with basal (long acting), basal-bolus, and premixed insulin regimens in a tertiary endocrinology outpatient clinic. METHODS: A total of 433 (mean age of 55.5±13.0 years; 52.4% females) insulin-naïve type 2 diabetic patients initiated on insulin therapy were included in this questionnaire-based phone interview survey at the sixth month of therapy. Via the telephone interview questions, patients were required to provide information about persistence to insulin treatment, self-reported blood glucose values, and side effects; data on demographics and diabetes characteristics were obtained from medical records. RESULTS: Self-reported treatment withdrawal occurred in 20.1% patients, while 20.3% patients were nonadherent to daily insulin. Negative beliefs about insulin therapy (24.1%) and forgetting injections (40.9%) were the most common reasons for treatment withdrawal and dose skipping, respectively. Younger age (49.5±15.0 vs 56.4±12.0 years) (P=0.001) and shorter duration of diabetes (4.8±4.3 vs 8.8±6.3 years) (P=0.0008) and treatment duration (5.2±2.4 vs 10.7±2.4 months) (P=0.0001) were noted, respectively, in discontinuers vs continuers. Basal bolus was the most commonly prescribed insulin regimen (51.0%), while associated with higher likelihood of skipping a dose than regular use (61.3% vs. 46.0%, P=0.04). CONCLUSIONS: Persistence to insulin therapy was poorer than anticipated but appeared to be higher in patients with the basal bolus regimen. Negative perceptions about insulin therapy seemed to be the main cause for poor adherence in our cohort.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Standards of medical care in diabetes—2014
American Diabetes Association (2014) · Diabetes Care · doi:10.2337/dc14-s014 · Cited by 4,572 · cited 1×
“35 37–39 Hence, given that more than two-thirds of continuers in our cohort had attended regular follow-up visits and that treatment discontinuation was based on a physician decision in 13.7% of discontinuers, the role of physician-related factors in insulin adherence should also be emphasized.”
InfluentialPhillips, L. S., Branch, W. T., Cook, C. B., Doyle, J. P., El-Kebbi, I. M., Gallina, D. L., Miller, C. D., Ziemer, D. C., & Barnes, C. S. (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-135-9-200111060-00012 · Cited by 1,370
A systematic review of adherence with medications for diabetes
Cramer, J. A. (2004) · Diabetes Care · doi:10.2337/diacare.27.5.1218 · Cited by 1,203
Peyrot, M., Barnett, A. H., Meneghini, L. F., & Schumm‐Draeger, P. ‐. (2012) · Diabetic Medicine · doi:10.1111/j.1464-5491.2012.03605.x · Cited by 655 · cited 2×
“According to the multinational GAPP survey, insulin omission/nonadherence was reported to be highest in Turkey, followed by the USA, People’s Republic of China, and Japan, and lowest in France, Germany, UK, and Spain.(8,12) Our findings are in line with a previous report of poor patient adherence in insulin therapy(15…”
Correlates of Insulin Injection Omission
Peyrot, M., Rubin, R. R., Kruger, D. F., & Travis, L. B. (2010) · Diabetes Care · doi:10.2337/dc09-1348 · Cited by 407 · cited 1×
“16 Our findings also coincide with previous study showing almost 60% of patients miss injections and 20% miss doses on a regular basis, 17 and a level of 16%–49% persistence at 6–12 months.”
Cited by
Guerci, B., Chanan, N., Kaur, S., Jasso-Mosqueda, J. G., & Lew, E. (2019) · Diabetes Therapy · doi:10.1007/s13300-019-0590-x · Cited by 106
“In the case of insulin regimen, for example, a higher daily insulin dose and greater regimen complexity may contribute to poorer treatment adherence [7, 8].”
BackgroundMissed and Mistimed Insulin Doses in People with Diabetes: A Systematic Literature Review
Robinson, S., Newson, R. S., Liao, B., Kennedy-Martin, T., & Battelino, T. (2021) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2021.0164 · Cited by 73
“16,18,27,41,42 Insulin use requires countless decisions each day regarding lifestyle behaviors and medication, and these complexities of self-management can represent a significant barrier to consistency of dosing.”
InfluentialSteenkamp, D., Eby, E. L., Gulati, N., & Liao, B. (2022) · Journal of Diabetes Science and Technology · doi:10.1177/1932296821997923 · Cited by 33
Sidorenkov, G., van Boven, J. F. M., Hoekstra, T., Nijpels, G., Hoogenberg, K., & Denig, P. (2018) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.13332 · Cited by 24
“One of the causes for this could be that younger patients may have a more irregular lifestyle and consequently more problems in adhering to treatment with insulin.(18,19) The higher prevalence of patients treated with sulfonylureas in this group may be an indicator of more severe illnesses.”
BackgroundSeo, J., Heidenreich, S., Aldalooj, E., Poon, J. L., Spaepen, E., Eby, E. L., & Newson, R. S. (2023) · The Patient - Patient-Centered Outcomes Research · doi:10.1007/s40271-022-00610-x · Cited by 19
Metadata
- Authors
- Yavuz, D., Ozcan, S., & Deyneli, O.
- Venue
- Patient Preference and Adherence
- Publisher
- Informa UK Limited
- Published
- 2015-08
- Volume
- 9
- Pages
- 1225
- ISSN
- 1177-889X (ISSN-L)
- OpenAlex
- W1878714189
- Cited by
- 80
- References
- 6
- FWCI
- 5.04
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.